Skip to main content
. 2020 Jul 29;10:12749. doi: 10.1038/s41598-020-69794-2

Table 4.

Relation of triglyceride quartiles to progression to overall and cardiovascular mortality using multivariate Cox proportional hazards model.

Non-HDL cholesterol Overall mortality Cardiovascular mortality
Hazard ratio (95% CI) p Hazard ratio (95% CI) p
Age and gender adjusted
 Quartile 1 1.612 (0.809–3.210) 0.175 2.717 (0.846–8.726) 0.093
 Quartile 2 Reference Reference
 Quartile 3 1.880 (0.971–3.640) 0.061 2.432 (0.747–7.918) 0.140
 Quartile 4 1.480 (0.747–2.933) 0.262 2.319 (0.713–7.542) 0.162
Multivariate adjusted (1)
 Quartile 1 1.835 (0.911–3.696) 0.089 3.180 (0.966–10.470) 0.057
 Quartile 2 Reference Reference
 Quartile 3 1.874 (0.950–3.697) 0.070 2.465 (0.736–8.263) 0.144
 Quartile 4 1.501 (0.741–3.039) 0.259 2.544 (0.758–8.538) 0.131
Multivariate adjusted (2)
 Quartile 1 2.081 (0.968–4.475) 0.061 5.545 (1.319–23.315) 0.019
 Quartile 2 Reference Reference
 Quartile 3 2.392 (1.121–5.107) 0.024 5.453 (1.169–25.430) 0.031
 Quartile 4 1.599 (0.706–3.623) 0.261 3.840 (0.793–18.597) 0.095

Values expressed as hazard ratio and 95% confidence interval (CI). Abbreviations are the same as in Table 1.

Multivariate model 1: adjusted for age, gender, smoking, diabetes mellitus, hypertension, coronary artery disease and congestive heart failure, underlying disease of CKD and BMI.

Multivariate model 2: adjusted for age, gender, smoking, diabetes mellitus, hypertension, coronary artery disease and congestive heart failure, underlying disease of CKD, BMI, systolic blood pressure ≧ 140 mmHg, fasting glucose, HbA1C, hemoglobin, eGFR < 30 ml/min/1.73 m2, total calcium, phosphorous, proteinuria, aspirin, ACEI and/or ARB, β-blocker, calcium channel blocker , diuretics and statin and/or fibrate use.